Documents
Application Sponsors
BLA 761097 | REGENERON PHARMACEUTICALS | |
Marketing Status
Application Products
001 | INJECTABLE;INTRAVENOUS | 350MG | 0 | LIBTAYO | CEMIPLIMAB-RWLC |
FDA Submissions
TYPE 1; Type 1 - New Molecular Entity | ORIG | 1 | AP | 2018-09-28 | PRIORITY |
LABELING; Labeling | SUPPL | 2 | AP | 2019-01-18 | STANDARD |
LABELING; Labeling | SUPPL | 3 | AP | 2020-11-10 | STANDARD |
EFFICACY; Efficacy | SUPPL | 5 | AP | 2020-06-25 | STANDARD |
EFFICACY; Efficacy | SUPPL | 7 | AP | 2021-02-22 | PRIORITY |
EFFICACY; Efficacy | SUPPL | 8 | AP | 2021-02-09 | PRIORITY |
EFFICACY; Efficacy | SUPPL | 9 | AP | 2021-02-09 | PRIORITY |
EFFICACY; Efficacy | SUPPL | 14 | AP | 2022-11-08 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 7 |
SUPPL | 2 | Null | 15 |
SUPPL | 3 | Null | 6 |
SUPPL | 5 | Null | 7 |
SUPPL | 7 | Null | 7 |
SUPPL | 8 | Null | 6 |
SUPPL | 9 | Null | 7 |
SUPPL | 14 | Null | 15 |
CDER Filings
REGENERON PHARMACEUTICALS
cder:Array
(
[0] => Array
(
[ApplNo] => 761097
[companyName] => REGENERON PHARMACEUTICALS
[docInserts] => ["Medication Guide","https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/761097s005lbl.pdf#page=15"]
[products] => [{"drugName":"LIBTAYO","activeIngredients":"CEMIPLIMAB-RWLC","strength":"350MG","dosageForm":"INJECTABLE;INTRAVENOUS","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"}]
[labels] => [{"actionDate":"06\/25\/2020","submission":"SUPPL-5","supplementCategories":"Efficacy-Labeling Change With Clinical Data","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/761097s005lbl.pdf\"}]","notes":""},{"actionDate":"03\/20\/2019","submission":"SUPPL-1","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/761097s001lbl.pdf\"}]","notes":""},{"actionDate":"01\/18\/2019","submission":"SUPPL-2","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/761097s002lbl.pdf\"}]","notes":""},{"actionDate":"09\/28\/2018","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/761097s000lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"09\/28\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"N\/A","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/761097s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2018\\\/761097Orig1s000ltr.pdf\"},{\"name\":\"Review\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2018\\\/761097Orig1s000TOC.cfm\"}]","notes":">"}]
[supplements] => [{"actionDate":"06\/25\/2020","submission":"SUPPL-5","supplementCategories":"Supplement","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/761097s005lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2020\\\/761097Orig1s005ltr.pdf\"}]","notes":">"},{"actionDate":"01\/18\/2019","submission":"SUPPL-2","supplementCategories":"Supplement","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/761097s002lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2019\\\/761097Orig1s002ltr.pdf\"}]","notes":">"},{"actionDate":"03\/20\/2019","submission":"SUPPL-1","supplementCategories":"Supplement","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/761097s001lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2019\\\/761097Orig1s001ltr.pdf\"}]","notes":">"}]
[actionDate] => 2020-06-25
)
)